]> Michel Dumontier Qualitative and quantitative measures of biomedical entities and their components. biomedical measure ontology (primitive) en http://dumontierlab.com 24 hour blood pressure A study recording the blood pressure at intervals during a 24-hour period. ASAA Concentration The concentration of a family of apolipoproteins associated with HDL in plasma ASAA concentration decrease ASAA concentration difference The difference in ASAA concentration. ASAA concentration increase acute phase serum amyloid measure Measure of acute phase serum amyloid airway responsiveness using methacholine A test measuring the dlnchial contractility of the airways after administration of Methacholine. anxiety measure A measure of anxiety asthma frequency The frequency of asthma during some time interval. biological measure Measurements applied to biological entities and their components. physical measure Measurements of a physical nature on an individual. blood pressure Measurement is divided into systolic (pressure during contraction of the heart) and diastolic (pressure during relaxation phase). blood serum protein count Measurements on proteins in blood serum. body mass index Body weight in kilograms divided by the height in meters squared. body mass index decrease a measured decrease in body mass index. body mass index difference a difference in body mass index. body mass index increase a measured increase in body mass index. body mass index measure A measure of body mass index. bone mineral density A nuclear medicine test that estimates the mineralization of bone in a subject. cell count E.g., CD4 cell counts child depression measure A measure of the severity of depression in children. child depression score A score that indicates the severity of depression in children. child depression score difference The difference in scores for child depression. clinical outcome measure The outcome or outcome assessment of a patient at the end of patient care. coagulation profile Measures the speed of blood coagulation at different steps of the coagulation pathway. cognitive measure Assessments of the mental status of a subject. daily blood pressure The blood pressure, measured daily. decreased gene expression depression measure A measure of depression. disease frequency The occurence of disease during some time interval. disease susceptibility odds The odds of developing a disease. dose The amount of a substance to which a person is exposed over some time period. dose frequency The frequency at which the dose is administered. drug clearance The rate of elimination of a drug, metabolite, or other substance from the body or organ of interest. drug efficacy A measure of the drug to realize a maximum therapeutic response. drug efficacy measure A measure of drug efficacy ER visit frequency The frequency of patient visits to the emergency room during some time interval. electrocardiogram QT interval An recording of the electrical activity of the heart contraction.Time from electrocardiogram Q wave to the end of the T wave corresponding to electrical systole. erythomycin clearance measure A metabolic measure of the clearance of Erythromycin. event free survival time The length of time a subject lives without having one or more complications of a disease. exercise response Physiological variations that occur when a subject partakes in a defined exercise activity. forced experiatory volume Forced Expiratory Volume in 1 second. forced vital capacity Forced Vital Capacity. This is the total amount of air a subject can blow out forcefully. gender gene expression A measure of the levels of mRNA produced from a gene. gene expression difference A measure of the change or difference in gene expression. gene expression measure A measure of gene expression. genotype measure hamilton anxiety score A measure of the severity of anxiety hamilton anxiety score difference The difference in hamilton anxiety score. hamilton depression measure hamilton depression score A measure the severity of depression. hamilton depression score difference The difference in hamilton depression score. high drug efficacy A measure of a drug to have great ability in realizing a therapeutic potential. high hamilton depression score high montgomery asberg depression rating high reduction in child depression score high reduction in hamilton anxiety score high reduction in hamilton depression score high reduction in montgomery asberg depression rating high remission high remission odds ratio higher disease susceptibility odds homocysteine level The quantity or amount of homocysteine in the in plasma, CSF, or other fluids. increased gene expression lipid profile Includes total cholesterol, HDL-cholesterol (often called good cholesterol), LDL-cholesterol (often called bad cholesterol), and triglycerides, and associated computed parameters. low drug efficacy A measure of a drug that is poor ability in realizing a therapeutic potential. low hamilton depression score low montgomery asberg depression rating low reduction in child depression score low reduction in hamilton anxiety score low reduction in hamilton depression score low reduction in montgomery asberg depression rating low remission low remission odds ratio lower disease susceptibility odds metabolic measure Measurement of the transformation of substances in the body. moderate hamilton depression score moderate montgomery asberg depression rating moderate reduction in child depression score moderate reduction in hamilton anxiety score moderate reduction in hamilton depression score moderate reduction in montgomery asberg depression rating moderate remission molecular measure montgomer asberg depression measure montgomery asberg depression rating A measure of antidepressant efficacy. montgomery asberg depression rating difference The difference in montgomery asberg depression rating. myocardial infarction frequency The frequency of medical events or conditions subsequent to heart attacks. neoplasm frequency The frequency of cancer development during some time interval. normal gene expression pathogen count E.g., viremia, fungemia, etc. pharmacodynamic measure A measure of pharmacodynamics. pharmacokinetic measure The amount of chemical agent at their sites of biological effect. plasma drug concentration The quantity or amount of drug in the blood plasma. population variation pulmonary function measure These are laboratory tests related to lung function. quality of life The individuals’ perceptions of their position in life, in the context of the cultural and value systems in which they live and in relation to their goals, expectations, standards and concerns. race remission frequency The occurence of abatement of symptoms during a time interval. remission measure A measure of remission. remission odds ratio renin/angiotensin system measure Measurements related to the renin/angiotensin system, such as Angiotensinogen, Angiotensin I/II, plasma renin, etc. satiety The feeling of fullness and disappearance of appetite satiety decrease satiety difference The difference in satiety from one time to another. satiety frequency The occurence of satiety during a time interval. satiety increase satiety measure A measure of the feeling of fullness and disappearance of appetite side effect frequency The number of times a side effect occurs during some time interval. side effect measure Measures of side effects. side effect rate The rate at which a side effect occurs when comparing one group (test) to another (control). similar disease susceptibility odds similar remission odds ratio taxonomic measure tissue measure Measurement of samples of blood or tissue from an individual. weight loss a measured decrease in weight. weigth measure A measure of weight. weight The vertical force exerted by a mass as a result of gravity. weight difference A measured difference in weight. weigth gain a measured increase in weight. zero drug efficacy A measure of a drug that has zero ability in realizing a therapeutic potential. zero remission